S&P 500 Futures
(-1.22%) 5 045.00 points
Dow Jones Futures
(-1.13%) 38 244 points
Nasdaq Futures
(-1.61%) 17 381 points
Oil
(0.08%) $82.88
Gas
(-1.69%) $1.625
Gold
(0.22%) $2 343.60
Silver
(0.76%) $27.56
Platinum
(-0.24%) $913.60
USD/EUR
(0.13%) $0.936
USD/NOK
(0.25%) $11.01
USD/GBP
(-0.09%) $0.802
USD/RUB
(-0.28%) $92.06

Realtime updates for Ikonisys S.A. [ALIKO.PA]

Exchange: EURONEXT Sector: Healthcare Industry: Medical Devices
Last Updated25 Apr 2024 @ 03:00

0.00% 1.430

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 03:00):

Ikonisys S.A., a cell based diagnostics company, engages in the design, manufacturing, marketing, and sale of medical diagnostic products for various cancers in the United States and Europe...

Stats
Today's Volume 1.00
Average Volume 8 126.00
Market Cap 14.95M
EPS €0 ( 2023-10-31 )
Last Dividend €0 ( N/A )
Next Dividend €0 ( N/A )
P/E -5.72
ATR14 €0 (0.00%)

Ikonisys S.A. Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Ikonisys S.A. Financials

Annual 2022
Revenue: €935 218
Gross Profit: €751 805 (80.39 %)
EPS: €-0.260
Q2 2023
Revenue: €128 909
Gross Profit: €-532 296 (-412.92 %)
EPS: €-0.0990
Q1 2023
Revenue: €64 455.00
Gross Profit: €50 046.00 (77.64 %)
EPS: €0
Q4 2022
Revenue: €409 654
Gross Profit: €-343 023 (-83.73 %)
EPS: €-0.150

Financial Reports:

No articles found.

Ikonisys S.A.

Ikonisys S.A., a cell based diagnostics company, engages in the design, manufacturing, marketing, and sale of medical diagnostic products for various cancers in the United States and Europe. It offers Ikoniscope Robotic Microscope that provides automated slide handling, slide scanning, and real-time image capture and analysis, and eliminates various factors that cause human error in testing; oncoFISH bladder that allows scanning and analysis of cells recovered from a voided urine sample; oncoFISH her2, a microscopy application for the determination of the HER2 status of tissue sections from breast tissue biopsies; and oncoFISH anaplastic lymphoma kinase (ALK), a microscopy application for the FISH based detection of rearrangements of the gene encoding anaplastic lymphoma kinase (ALK). The company also provides oncoFISH PTEN, a microscopy application for the FISH based detection of deletions of the PTEN gene is prostate tissue biopsies; circulating tumor cells for characterization of individual tumor cells and ctDNA for global tumor genotype information; Ikonisoft explorer CS, a FISH scanning application for analysis of cell suspension deposited on a slide that has been hybridized with desired combination of FISH probes; Ikonisoft explorer tissue, a FISH scanning application for analysis of various tissue section hybridized with desired combination of FISH probes; and IkoniWAN Gateway, a validated remote access solution for Ikoniscope digital microscopy systems. Ikonisys S.A. is based in Paris, France.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators